Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial

Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial

The Bacillus Calmette-Guérin (BCG) vaccine, which is widely used to protect children against tuberculosis, can also improve immune response against viral infections. This unicentric, randomized-controlled clinical trial assessed the efficacy and safety of revaccination with BCG Moscow in reducing th...

Full description

Bibliographic Details
Main Authors: Laura Raniere Borges dos Anjos, Adeliane Castro da Costa, Amanda da Rocha Oliveira Cardoso, Rafael Alves Guimarães, Roberta Luiza Rodrigues, Kaio Mota Ribeiro, Kellen Christina Malheiros Borges, Ana Carolina de Oliveira Carvalho, Carla Iré Schnier Dias, Aline de Oliveira Rezende, Carine de Castro Souza, Renato Rodney Mota Ferreira, Guylherme Saraiva, Lilia Cristina de Souza Barbosa, Tayro da Silva Vieira, Marcus Barreto Conte, Marcelo Fouad Rabahi, André Kipnis, Ana Paula Junqueira-Kipnis
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Immunology
Subjects:
NK cells
innate response
cross protection
respiratory infection
symptoms
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.841868/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.841868/full

Similar Items